Curis | CRIS - Операционные расходы





Операционные расходы Изменить Дата
Alaunos Therapeutics USD 1.01M 175K 2026-03
Amgen USD 4.78B 1.12B 2026-03
AstraZeneca USD 8.18B 4.35B 2026-03
Bayer EUR 9.88B 452M 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
CSL USD 5.7B 2.82B 2025-12
Curis USD 9.02M 23.01M 2025-12
Eli Lilly USD 10.02B 285M 2026-03
Exelixis USD 359.47M 3.28M 2026-03
Gilead Sciences USD 23.52B 18.55B 2026-03
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Incyte USD 5.62B 4.5B 2026-03
Merck USD 18.17B 8.01B 2026-03
Novartis USD 9.29B 507M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
Takeda JPY 1.11T 85.29B 2026-03
TG Therapeutics USD 170.12M 28.04M 2026-03
Verastem USD 59.01M 21.98M 2025-12
Xoma USD 22.84M 1.67M 2024-09